Alan Lenox‐Smith
- Biological Psychiatry top 10%
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research 5
- Electroconvulsive Therapy Studies 3
- Pharmacology top 5%
- Treatment of Major Depression 13
-
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 6
- Geriatrics and Gerontology top 10%
-
- Child and Adolescent Psychosocial and Emotional Development 5
-
- Health Systems, Economic Evaluations, Quality of Life 4
-
- Mental Health Treatment and Access 3
-
- Neurotransmitter Receptor Influence on Behavior 3
Alan Lenox‐Smith
26 papers receiving 468 citations
Peers
Comparison fields: 5 of 80
- Biological Psychiatry 37
- Psychiatry and Mental health 194
- Pharmacology 203
- Experimental and Cognitive Psychology 136
- Geriatrics and Gerontology 29
Countries citing papers authored by Alan Lenox‐Smith
This map shows the geographic impact of Alan Lenox‐Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Lenox‐Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Lenox‐Smith more than expected).
Fields of papers citing papers by Alan Lenox‐Smith
This network shows the impact of papers produced by Alan Lenox‐Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Lenox‐Smith. The network helps show where Alan Lenox‐Smith may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan Lenox‐Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 6 | |
| 2 | 2018 | 21 | |
| 3 | 2016 | 24 | |
| 4 | 2015 | 28 | |
| 5 | 2014 | 19 | |
| 6 | 2014 | 26 | |
| 7 | 2014 | 8 | |
| 8 | 2014 | 38 | |
| 9 | 2013 | 19 | |
| 10 | 2013 | 5 | |
| 11 | 2013 | 30 | |
| 12 | 2012 | 6 | |
| 13 | 2010 | 18 | |
| 14 | 2009 | 13 | |
| 15 | 2008 | 52 | |
| 16 | 2005 | 13 | |
| 17 | 2004 | 23 | |
| 18 | A double-blind, randomised, placebo controlled study of venlafaxine XL in patients with generalised anxiety disorder in primary care. | 2003 | 44 |
| 19 | 2002 | 1 | |
| 20 | 2000 | 25 |
About Alan Lenox‐Smith
Alan Lenox‐Smith is a scholar working on Psychiatry and Mental health, Pharmacology, Experimental and Cognitive Psychology, Biological Psychiatry and Clinical Psychology, having authored 26 papers that have together received 497 indexed citations. Recurring topics across this work include Treatment of Major Depression (13 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (6 papers), Dementia and Cognitive Impairment Research (5 papers), Child and Adolescent Psychosocial and Emotional Development (5 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Electroconvulsive Therapy Studies (3 papers), Mental Health Treatment and Access (3 papers) and Neurotransmitter Receptor Influence on Behavior (3 papers). The work is most often cited by research in Biological Psychiatry (37 citations), Psychiatry and Mental health (194 citations), Pharmacology (203 citations), Experimental and Cognitive Psychology (136 citations) and Geriatrics and Gerontology (29 citations). Alan Lenox‐Smith has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Qin Jiang, Andrew Bradley, Catherine Reed, Alan Reynolds, Mark Belger, David Taylor, Roy Jones, Michael Happich, Jérémie Lebrec and C Knight. Their work appears in journals such as BMC Geriatrics, PharmacoEconomics, Journal of Psychopharmacology, European Neuropsychopharmacology and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.